SEC Company Response from Scilex Holding (SCLX) — Dec 23, 2025
Scilex Holding Co
Date: Dec. 23, 2025 · CIK: 0001820190 · Accession: 0001193125-25-330492
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292157
Letter
Re: Scilex Holding Company Registration Statement on Form S-1, filed on December 16, 2025 File No. 333-292157 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Scilex Holding Company (the “ Company ”) hereby respectfully requests that the effectiveness of the Registration Statement on Form S-1 (File No. 333-292157) of the Company, filed with the Securities and Exchange Commission on December 16, 2025 (the “ Registration Statement ”) be accelerated so that the Registration Statement shall become effective at 4:00 p.m. (Eastern Time) on December 29, 2025, or as soon as possible thereafter. The Company hereby confirms that it is aware of its responsibilities under the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended, as they relate to the proposed offering of the securities specified in the Registration Statement. It would be appreciated if, promptly after the Registration Statement has become effective, you would so inform our outside counsel, Jeffrey T. Hartlin of Paul Hastings LLP, by telephone at (650) 320-1804 or by email at jeffhartlin@paulhastings.com, and Elizabeth A. Razzano of Paul Hastings LLP, by telephone at (650) 320-1895 or by email at elizabethrazzano@paulhastings.com. The Company hereby authorizes Mr. Hartlin or Ms. Razzano of Paul Hastings LLP to orally modify or withdraw this request for acceleration.
Scilex Holding Company 960 San Antonio Road Palo Alto, CA 94303 December 23, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Attention: Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549-0406
Sincerely,
SCILEX HOLDING COMPANY
Show Raw Text
CORRESP 1 filename1.htm CORRESP Scilex Holding Company 960 San Antonio Road Palo Alto, CA 94303 December 23, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Attention: Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549-0406 Re: Scilex Holding Company Registration Statement on Form S-1, filed on December 16, 2025 File No. 333-292157 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Scilex Holding Company (the “ Company ”) hereby respectfully requests that the effectiveness of the Registration Statement on Form S-1 (File No. 333-292157) of the Company, filed with the Securities and Exchange Commission on December 16, 2025 (the “ Registration Statement ”) be accelerated so that the Registration Statement shall become effective at 4:00 p.m. (Eastern Time) on December 29, 2025, or as soon as possible thereafter. The Company hereby confirms that it is aware of its responsibilities under the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended, as they relate to the proposed offering of the securities specified in the Registration Statement. It would be appreciated if, promptly after the Registration Statement has become effective, you would so inform our outside counsel, Jeffrey T. Hartlin of Paul Hastings LLP, by telephone at (650) 320-1804 or by email at jeffhartlin@paulhastings.com, and Elizabeth A. Razzano of Paul Hastings LLP, by telephone at (650) 320-1895 or by email at elizabethrazzano@paulhastings.com. The Company hereby authorizes Mr. Hartlin or Ms. Razzano of Paul Hastings LLP to orally modify or withdraw this request for acceleration. Sincerely, SCILEX HOLDING COMPANY By: /s/ Henry Ji Henry Ji Chief Executive Officer and President cc: Jeffrey T. Hartlin (Paul Hastings LLP) Elizabeth A. Razzano (Paul Hastings LLP)